If you have CLL, why worry says Forbes Magazin... - CLL Support
If you have CLL, why worry says Forbes Magazine..!!
You need to be a member of this community to see this post.
Read more about...
22 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Forbes says: "With So Many Terrific New Drugs For Chronic Lymphocytic Leukemia (CLL), Why Worry?" I say it's a Tempest in A Teapot
Friends,
The Forbes article has received much play and with the able help of our friend Andrew...
Revolution of Chronic Lymphocytic LeukemiaTherapy: the Chemo-Free Treatment Paradigm
[Here is some info that may be useful to read - or again go over again . . . ]
Annika Scheffold1 &...
FDA Approves Venetoclax (VENCLEXTA) For CLL or SLL with or without 17p deletion, who have received at least one prior therapy
FDA Approves Venetoclax (VENCLEXTA) For Chronic Lymphocytic Leukemia or Small Lymphocytic...
Determining if you'll never need treatment. It is feasible and safe to stop specialized follow-up of asymptomatic lower risk CLL?
Regular readers will have often heard that around 30% of those diagnosed with CLL never need...
Trabectedin Targets Leukemic Cells and Restores Immune Cell Function in Models of Chronic Lymphocytic Leukemia
The marine-derived compound trabectedin depletes both human primary leukemic cells and...
Related Posts
- CLL Society COVID-19 guidelines, & Explaining to Family and Friends Why the CDC Guidelines for Those Vaccinated - Do Not Apply to us
ASH 2023 Unveils A “New Gold Standard” for CLL TreatmentUpdated Jan 17, 2024ByRuth FeinMedical ReviewerKerry A. Rogers, MD- Zanubrutinib vs. Ibrutinib Patient Power Video by Dr. Jennifer Brown MD PHD
- If you want to learn about CLL text or video
Dr. Wierda on the paradigm shift in CLL.
